Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regional citrate anticoagulation during sustained low-efficiency dialysis
ChiCTR-TRC-11001582Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of trisodium citrate and heparin in acute kidney failure (AKF) and chronic kidney disease (CKD) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Coagulation indexes, 30-day and 60-day survival rate and 8 more. Started Jan 2011; status: completed.
02
Drugs
trisodium citrateheparin
03
Conditions
acute kidney failure (AKF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR-TRC-11001582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001582.